MB, Levis & Associates’s Kyndryl KD Stock Holding History
Bought
Maintained
Sold
Other funds holding KD
VPM
VCM
SSM
MB, Levis & Associates's KD Position: Q1 2026 in Review
MB, Levis & Associates reduced its Kyndryl (KD) stake by 7.1% in Q1 2026, selling an estimated $264 and leaving 195 shares worth $2.56K. The position accounts for ﹤0.01% of the portfolio, ranked #202.
MB, Levis & Associates first reported a position in KD in Q4 2022 and has held it in 14 quarters since. The position peaked at $8.81K in Q2 2025. 660 funds tracked by Wall St. Rank hold KD as of Q1 2026.
- MB, Levis & Associates held 195 shares of Kyndryl worth $2.56K as of Q1 2026.
- MB, Levis & Associates sold 15 Kyndryl shares in Q1 2026, an estimated $264.
- Kyndryl made up ﹤0.01% of MB, Levis & Associates's portfolio in Q1 2026, its #202 holding.
- MB, Levis & Associates first reported a position in Kyndryl in Q4 2022 and has held it in 14 quarters since.
- MB, Levis & Associates's Kyndryl position peaked at $8.81K in Q2 2025.
- 660 funds tracked by Wall St. Rank held Kyndryl as of Q1 2026.
Based on MB, Levis & Associates's 13F filing for Q1 2026, filed 8 Apr 2026.